Investor Atlas

2080 Ventures · Investor research

38 investors focused on Cannabis targeting Switzerland

Compare 38 investors focused on Cannabis targeting Switzerland. Review the selection, investor types and reported focus with 2080 Ventures.

38matching investors
3individual investors
35organizations

What this selection covers

This guide contains 38 distinct directory identities matching target markets: Switzerland; sectors: Cannabis. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Switzerland” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (24), Private Equity (5), Accelerator (3), Angel Investor (3).

Prepare a focused approach

For Cannabis, compare the investor’s thesis and recent portfolio with your customer, business model and technical needs. A broad sector tag alone does not establish fit.

Before pitching for Switzerland, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 38 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
ABAB (Atlantic Business Angels Booster)
Angel NetworkView profile ↗
Abingworth
Venture CapitalView profile ↗
Aisling Capital
Private EquityView profile ↗
Altitude Investment Management
Venture CapitalView profile ↗
Amino Collective
Venture CapitalView profile ↗
Arcanum Ventures
Venture CapitalView profile ↗
Ardian
Private EquityView profile ↗
Arkin Holdings
Private EquityView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
EXPERT DOJO
Venture Capital, AcceleratorView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
Forty51 Ventures
Venture CapitalView profile ↗
General Inception
Startup StudioView profile ↗
Ginkgo Equity
Venture CapitalView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
HBM Partners
Private EquityView profile ↗
Henry Stebbins
Angel InvestorView profile ↗
HomeLab Powered By LabFellows
AcceleratorView profile ↗
Humboldt Fund
Venture CapitalView profile ↗
IndieBio
Venture CapitalView profile ↗
Innoviva
Venture CapitalView profile ↗
Medin VC
Venture CapitalView profile ↗
Michael Wieser
Angel InvestorView profile ↗
Mindshift Ventures
Venture CapitalView profile ↗
Mission BioCapital
Venture CapitalView profile ↗
Mountain Labs
Venture CapitalView profile ↗
Nelli Morgulchik
Angel InvestorView profile ↗
OrbiMed
Private EquityView profile ↗
Panakes Partners
Venture CapitalView profile ↗
Polaris Partners
Venture CapitalView profile ↗
Pureos Bioventures
Venture CapitalView profile ↗
SEE UP Accelerator
AcceleratorView profile ↗
Sofinnova Partners
Venture CapitalView profile ↗
TVM Capital
Venture CapitalView profile ↗
Venga Ventures
Venture CapitalView profile ↗
Wellcome Trust
Public FundView profile ↗
Young Ventures
Venture CapitalView profile ↗
ZAKA VC
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.